Skip to content

Embecta Corp. EMBC Gross Profit

Gross Profit at other companies

Insulet logo
InsuletPODD
$529M+29.3%
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
$136.79M+15.5%
Medtronic logo
MedtronicMDT
$6.41B+10.9%
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
$4.46M-68.1%
Mannkind logo
MannkindMNKD
$82.66M+10.8%
Beta Bionics, Inc. Common Stock logo
Beta Bionics, Inc. Common StockBBNX
$16.44M+83.2%

Other financials

Income statement

See full
Revenue$221.8M-14.4%
Operating income$35.0M-44.4%
Net income-$4.1M-117%
EPS (diluted)-$0.07-118%

Balance sheet

See full
Cash & equivalents$193.4M-8.9%
Total debt$1.4B-12.5%
Total equity-$626.1M+15.0%
Total assets$1.0B-8.1%

Cash flow

See full
Operating cash flow$31.1M-2.2%
CapEx$500.0K+400%
Free cash flow$30.6M-3.5%

Valuation

See full
Market cap$193.41M-64.3%
Enterprise value$1.37B-24.8%
P/E1.7×-4.8×
P/S0.2×-0.3×

Profitability

See full
Gross margin61.9%-1.6pp
Operating margin25.8%+9.7pp
Net margin10.7%+5.8pp
FCF margin19.6%+16.0pp

Returns & leverage

See full
Return on equity71.9%
Debt / equity
Current ratio2.5×0.0×

Where this comes from

Calculated from Embecta Corp.’s reported figures.

The official record: Embecta Corp.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Embecta Corp.'s gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Embecta Corp.'s gross profit?
Embecta Corp. (EMBC) reported gross profit of $127.8M in Q1 2026.
How has Embecta Corp.'s gross profit changed year-over-year?
Embecta Corp.'s gross profit decreased by 22.1% year-over-year, from $164.1M to $127.8M.
What is the long-term trend for Embecta Corp.'s gross profit?
Over 4 years (2021 to 2025), Embecta Corp.'s gross profit has grown at a -4.1% compound annual growth rate (CAGR), from $800.4M to $676.8M.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.